|
|
Quantrx Biomedical Corporation (QTXB) |
|
|
|
Quantrx Biomedical's Quick Ratio
QTXB's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth
Select the Comparisons :
|
|
Select the Ratio:
|
|
QTXB Quick Ratio |
(Sep 30 2022) III. Quarter |
(Jun 30 2022) II. Quarter |
(Mar 31 2022) I. Quarter |
(Dec 31 2021) IV. Quarter |
(Sep 30 2021) III. Quarter |
Y / Y Current Liabilities Change |
16.15 % |
8.39 % |
1.23 % |
8.61 % |
9.35 % |
Y / Y Cash & cash equivalent Change |
-81.55 % |
-94.07 % |
-87.79 % |
-89.27 % |
-65.64 % |
Quick Ratio MRQ |
0 |
0 |
0 |
0 |
0.01 |
QTXB's Total
Ranking |
# 5763 |
# 5288 |
# 5374 |
# 5068 |
# 5514 |
Seq. Current Liabilities Change |
9.53 % |
2.02 % |
2.17 % |
1.74 % |
2.21 % |
Seq. Cash & cash equivalent Change |
135.97 % |
-72.2 % |
-0.5 % |
-71.74 % |
-24.16 % |
Quick Ratio third quarter 2022 Company Ranking |
Within: |
No. |
Medical Equipment & Supplies Industry |
# 205 |
Healthcare Sector |
# 1201 |
Overall Market |
# 5763 |
Quick Ratio Statistics |
High |
Average |
Low |
0.21 |
0.06 |
0 |
(Dec 31 2017) |
|
(Dec 31 2016) |
Cumulative Quantrx Biomedical's Quick Ratio
QTXB's Quick Ratio for the trailling 12 Months
QTXB Quick Ratio |
(Sep 30 2022) III. Quarter |
(Jun 30 2022) II. Quarter |
(Mar 31 2022) I. Quarter |
(Dec 31 2021) IV. Quarter |
(Sep 30 2021) III. Quarter |
Y / Y Current Liabilities TTM Growth |
16.15 % |
8.39 % |
1.23 % |
8.61 % |
9.35 % |
Y / Y Cash & cash equivalent TTM Growth |
-81.55 % |
-94.07 % |
-87.79 % |
-89.27 % |
-65.64 % |
Quick Ratio TTM |
0 |
0 |
0.01 |
0.01 |
0.02 |
Total
Ranking TTM |
#
| #
| #
| #
| #
|
Seq. Current Liabilities TTM Growth |
9.53 % |
2.02 % |
2.17 % |
1.74 % |
2.21 % |
Seq. Cash & cash equivalent TTM Growth |
135.97 % |
-72.2 % |
-0.5 % |
-71.74 % |
-24.16 % |
On the trailing twelve months basis In Spite of the rise in Current Liabilities in the III Quarter 2022 to $2.81 millions, cumulative Quick Ratio | |